Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/20964
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMitselou, A.en
dc.contributor.authorVougiouklakis, T. G.en
dc.contributor.authorPeschos, D.en
dc.contributor.authorDallas, P.en
dc.contributor.authorBoumba, V. A.en
dc.contributor.authorAgnantis, N. J.en
dc.date.accessioned2015-11-24T19:11:49Z-
dc.date.available2015-11-24T19:11:49Z-
dc.identifier.issn0250-7005-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/20964-
dc.rightsDefault Licence-
dc.subjectCarcinoembryonic Antigen/biosynthesisen
dc.subjectCarcinoma, Papillary/diagnosis/*metabolism/pathologyen
dc.subjectDiagnosis, Differentialen
dc.subjectHumansen
dc.subjectHyperplasiaen
dc.subjectImmunohistochemistryen
dc.subjectKeratins/biosynthesisen
dc.subjectMucin-1/biosynthesisen
dc.subjectNeoplasm Proteins/*biosynthesisen
dc.subjectS100 Proteins/biosynthesisen
dc.subjectThyroid Diseases/diagnosis/metabolism/pathologyen
dc.subjectThyroid Gland/pathologyen
dc.subjectThyroid Neoplasms/diagnosis/*metabolism/pathologyen
dc.subjectTumor Markers, Biological/*biosynthesisen
dc.titleImmunohistochemical study of the expression of S-100 protein, epithelial membrane antigen, cytokeratin and carcinoembryonic antigen in thyroid lesionsen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/12168868-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate2002-
heal.abstractThe diagnosis of papillary carcinoma of the thyroid is based on the two morphological features that best characterize this tumor, the papillae and the nuclear changes. However, both the architectural and cytological hallmarks may be encountered in other conditions such as multinodular goiter, Grave's disease, thyroiditis and hyperplastic areas of follicular neoplasms and thus produce problems in the histopathological interpretation. The distinction of these lesions from papillary carcinoma has important implications for clinical management. Thus the availability of supportive diagnostic evidence would be helpful. In the present study we compared the immunoreactivity for S-100 protein, epithelial membrane antigen (EMA), cytokeratin (Ck) and carcynoembryonic antigen (CEA) in different thyroid pathologies. We conclude that the strong expression of S-100 protein, in combination with EMA expression, is of value in identifying papillary neoplasia and distinguishing it from papillary hyperplasia.en
heal.journalNameAnticancer Resen
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
There are no files associated with this item.


This item is licensed under a Creative Commons License Creative Commons